Which of the following anesthetic drugs is contraindicated in chronic renal failure?
In extraction, the best time to administer analgesics is:
True about epidural opioid are all except:
Which opioid drug is effectively administered via the transbuccal route?
What are the advantages associated with the use of ketamine?
In the initial management of a hemodynamically unstable polytrauma patient, what is the recommended initial crystalloid bolus dose of Ringer's lactate for assessment and stabilization?
All are management of PDPH except-
Which of the following pain medications requires the MOST caution in a patient with a history of opioid addiction?
Which of the following anaesthetic agent lacks analgesic effect? A) N2O B) Thiopentone C) Methohexitone D) Ketamine E) Fentanyl
A two month old infant has undergone a major surgical procedure. Regarding postoperative pain relief which one of the following is recommended:
Explanation: ***Pethidine*** - **Pethidine** is contraindicated in chronic renal failure due to its active metabolite, **normeperidine**, which is eliminated renally. - Accumulation of **normeperidine** can lead to **central nervous system (CNS) toxicity**, including seizures, tremors, and hyperreflexia. *Atracurium* - **Atracurium** undergoes **Hofmann elimination** and **ester hydrolysis**, which are independent of renal or hepatic function. - This makes it a relatively safe choice for patients with **renal impairment**. *Fentanyl* - **Fentanyl** is primarily metabolized by the liver, with its metabolites being inactive. - While some dose adjustment may be considered in severe renal failure, it is generally **safe** for use in patients with chronic renal impairment as its metabolites are inactive. *Morphine* - **Morphine** is metabolized in the liver to **morphine-3-glucuronide (M3G)** and **morphine-6-glucuronide (M6G)**, both of which are renally excreted. - **M6G** is an active metabolite with potent analgesic effects, and its accumulation in renal failure can cause **prolonged sedation** and **respiratory depression**. While significant caution and dose reduction are needed, it's not strictly contraindicated in the same way pethidine is due to the more neurotoxic nature of normeperidine.
Explanation: ***Prior to the procedure*** - Administering analgesics **preemptively** helps to reduce the overall perception of pain post-operatively by blocking pain pathways before they are fully activated. - This approach is known as **preemptive analgesia** and has been shown to reduce post-operative pain intensity and analgesic consumption. *After anaesthesia has worn off* - Waiting until the anesthesia has worn off means the patient will likely experience the onset of significant pain, making it harder to control effectively. - This approach is reactive rather than proactive, and does not leverage the benefits of **preemptive pain management**. *When pain is moderate to severe* - At this point, the pain is already established and may be more difficult to manage, requiring higher doses or stronger analgesics. - **Pain management** is more effective when initiated before pain becomes severe, preventing the sensitization of pain pathways. *Just before anaesthesia wears off* - While this is better than waiting until the anesthesia has completely worn off, it still misses the opportunity for **preemptive analgesia**. - The pain pathways may already be activated or becoming sensitized as the anesthetic effect diminishes, making it less effective than administering prior to the procedure.
Explanation: **Function of the intestine is not affected** - **Epidural opioids** can indeed cause **constipation** and other gastrointestinal side effects by affecting opioid receptors in the **gut wall**, thus disturbing normal intestinal motility. - The phrase "not affected" is incorrect because **opioids inherently reduce gastrointestinal motility**, leading to common side effects such as nausea, vomiting, and constipation. *Act on dorsal horn substantia gelatinosa* - This statement is true; **epidural opioids work primarily by binding to opioid receptors** in the **substantia gelatinosa** of the dorsal horn of the spinal cord. - This binding **inhibits the release of neurotransmitters** like substance P, thus preventing the transmission of pain signals. *Can cause Itching* - **Pruritus (itching)** is a very common side effect of **epidural opioids**, often concentrated around the face and trunk. - It results from the **activation of opioid receptors** in the central nervous system and the release of histamine. *Can cause respiratory depression* - **Respiratory depression** is a serious and potentially life-threatening side effect of **epidural opioids**, particularly with higher doses or systemic absorption. - It occurs due to the **suppression of the medullary respiratory centers** in the brainstem.
Explanation: ***Fentanyl*** - **Fentanyl** is a potent, **lipophilic opioid** that is well-absorbed through mucous membranes, making it suitable for **transbuccal administration**. - Its high potency and rapid onset of action when administered transbuccally make it useful for breakthrough pain or rapid analgesia. *Sulfentanil* - While also a potent opioid, **sulfentanil** is primarily used intravenously for anesthesia and is not commonly formulated or administered via the transbuccal route. - Its chemical properties and pharmacokinetic profile do not lend themselves as readily to transbuccal absorption compared to fentanyl for practical clinical use. *Remifentanil* - **Remifentanil** is an **ultra-short-acting opioid** metabolized by plasma esterases, making it ideal for continuous intravenous infusions where rapid offset is desired. - Its rapid metabolism and specific pharmacokinetic properties make it unsuitable for transbuccal extended release or sustained absorption. *Alfentanil* - **Alfentanil** is a short-acting opioid predominantly used intravenously for induction and maintenance of anesthesia. - Although it has a rapid onset, it is not optimized or commonly utilized for transbuccal administration due to its lower lipophilicity and different absorption characteristics compared to fentanyl.
Explanation: ***All of the above*** - Ketamine provides a unique combination of **rapid onset of anesthesia**, potent **analgesia**, and desirable physiological effects, making it versatile for various clinical scenarios. - Its ability to induce **dissociative anesthesia** while maintaining spontaneous respiration and cardiovascular stability distinguishes it from many other anesthetic agents. *Rapid onset of anesthesia and analgesia* - This is a key advantage, as ketamine quickly achieves an anesthetic state and provides robust pain relief. - Its rapid action allows for efficient induction and management in emergency settings or procedures requiring prompt intervention. *Bronchodilation and preserved airway reflexes* - Ketamine's **bronchodilatory effect** makes it a favorable choice in patients with reactive airway diseases like asthma. - The **preservation of airway reflexes** helps protect against aspiration, which is a significant benefit compared to other anesthetics that depress these reflexes. *Cardiovascular stability with minimal respiratory depression* - Ketamine typically causes an increase in **heart rate and blood pressure**, contributing to cardiovascular stability, especially in patients with compromised hemodynamics. - Compared to many other anesthetics, ketamine causes **minimal respiratory depression**, maintaining spontaneous breathing and reducing the need for mechanical ventilation.
Explanation: ***1000 ml Ringer's lactate bolus, then regulated by clinical indicators*** - For **hemodynamically unstable** polytrauma patients, the initial recommended crystalloid bolus is typically **1 liter (1000 mL)** of Ringer's lactate. - This initial bolus allows for rapid assessment of the patient's response and guides subsequent fluid management based on **clinical indicators** such as blood pressure, heart rate, and urine output, avoiding over-resuscitation. *2000 ml Ringer's lactate bolus* - A **2000 ml bolus** is generally considered too large for an initial dose in trauma, as it can lead to **dilutional coagulopathy**, worsening hemorrhage, and **abnormal fluid shifts**, especially in cases where definitive hemorrhage control is not yet achieved. - Excessive fluid administration can lead to complications such as **abdominal compartment syndrome** and **acute respiratory distress syndrome (ARDS)**. *250 ml Ringer's lactate bolus* - A **250 ml bolus** is generally too small to effectively address **hemodynamic instability** in a polytrauma patient, offering insufficient volume to significantly improve circulation or organ perfusion. - While small boluses might be used in specific situations (e.g., small children or patients with cardiac comorbidities), this dose is not adequate for initial resuscitation in a severely unstable adult trauma patient. *500 ml Ringer's lactate bolus, then regulated by clinical indicators* - While **500 mL** is a common bolus size in other medical settings, it may be insufficient for the initial resuscitation of a **hemodynamically unstable adult polytrauma patient**. - Current trauma guidelines often recommend a larger initial bolus (e.g., 1000 mL) to gain a more immediate and measurable hemodynamic response for assessment.
Explanation: ***Stool softeners*** - While **stool softeners** may be prescribed to prevent **straining** in patients experiencing PDPH, they do not directly treat the underlying cause or symptoms of PDPH. - The primary goal of PDPH management is to re-establish **CSF pressure** and relieve headache, which stool softeners do not achieve. *Analgesic + caffeine* - **Caffeine** is a common component of PDPH management as it causes **cerebral vasoconstriction**, which can help alleviate the headache. - **Analgesics** (e.g., NSAIDs, opioids) are used to manage the pain associated with PDPH. *Intravenous / oral fluids* - Increasing **fluid intake**, both oral and intravenous, helps to promote **CSF production** and potentially increase intracranial pressure, thereby alleviating PDPH symptoms. - This is a supportive measure for rehydration and to potentially restore **CSF volume**. *Upright position* - An **upright position** typically **worsens** PDPH symptoms because it increases the gravitational pull on the CSF, further lowering intracranial pressure. - Patients with PDPH are usually advised to maintain a **supine (flat)** position to minimize headache severity.
Explanation: ***Morphine*** - Morphine is a **full mu-opioid agonist** with the highest potential for **abuse, dependence, and relapse** in patients with a history of opioid addiction due to its strong **euphoric effects**. - It carries the greatest risk of triggering **addictive behaviors** and relapse in recovering patients, making it require the MOST caution in this population. - Use should be avoided if possible, or limited to short-term use under strict supervision with alternative analgesics preferred. *Oxycodone* - Oxycodone is another **potent full opioid agonist** with very high abuse potential, nearly equivalent to morphine. - While requiring extreme caution, morphine remains the prototypical high-risk opioid in addiction-prone patients. *Methadone* - Methadone is a **long-acting full opioid agonist** used in opioid maintenance therapy with significant abuse potential. - However, when used appropriately in supervised programs, it has a role in addiction treatment, though acute pain prescribing requires caution due to its **long half-life and QTc prolongation risk**. *Buprenorphine* - Buprenorphine is a **partial mu-opioid agonist** with a **ceiling effect** that limits respiratory depression and euphoria. - It is the **standard medication for opioid use disorder treatment** and has LOWER abuse potential than full agonists. - While it requires careful timing to avoid precipitated withdrawal in opioid-dependent patients, it is actually SAFER than full agonists in patients with addiction history due to reduced relapse risk.
Explanation: ***Thiopentone*** - Thiopentone is a **barbiturate** anesthetic primarily used for inducing anesthesia. - It provides significant **hypnosis** and sedation but lacks intrinsic **analgesic properties**, meaning it does not relieve pain. *N2O* - **Nitrous oxide** (N2O) is an inhalation anesthetic that provides good **analgesia** at sub-anesthetic concentrations. - It is often used as an adjunct to other anesthetic agents to enhance pain relief during procedures. *Methohexitone* - Methohexitone is another **barbiturate** similar to thiopentone, used for induction of anesthesia. - While it provides rapid **hypnosis**, it also lacks significant **analgesic effects**. *Ketamine* - Ketamine is a **dissociative anesthetic** known for its potent **analgesic properties**. - It works by blocking **NMDA receptors**, providing pain relief even at sub-anesthetic doses. *Fentanyl* - Fentanyl is a powerful **opioid analgesic** that is commonly used in anesthesia for its strong pain-relieving effects. - It acts on **opioid receptors** in the central nervous system to reduce pain perception.
Explanation: ***Intravenous narcotic infusion in lower dosage*** - **Intravenous narcotic infusion** provides continuous pain relief and allows for careful titration of the dose, which is crucial in infants due to their developing metabolism and increased sensitivity to opioids. - Lower dosages are recommended because infants have a **reduced capacity for drug metabolism** and excretion, making them more susceptible to side effects like respiratory depression. *Spinal narcotics intrathecal route* - While effective, the **intrathecal route** carries risks such as neurotoxicity and spinal cord injury, which are particularly concerning in infants due to their small size and developing neural structures. - The **pharmacokinetics** of intrathecal narcotics can also be unpredictable in infants, leading to potential for delayed respiratory depression. *Only paracetamol suppository is adequate* - For **major surgical procedures**, a single agent like **paracetamol** is typically insufficient to manage severe postoperative pain effectively. - While paracetamol is a useful adjunct, it lacks the potent analgesic effects of opioids needed for comprehensive pain control after significant surgery. *No medication is needed as infant does not feel pain after surgery due to immaturity of nervous system* - This statement is **incorrect** and a dangerous misconception; infants, even neonates, have a **fully developed pain pathway**, perceive pain, and require appropriate analgesia. - The **pain response** in infants can be more exaggerated due to an immature inhibitory pain system, necessitating careful and effective pain management.
Get full access to all questions, explanations, and performance tracking.
Start For Free